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Neuroendocrine carcinoma (NEC) rarely metastasizes 
to the skin, and hence very few cases of cutaneous 
metastases of pancreatic NEC have been reported [1, 2]. 
The identification of the primary site in metastatic NEC 
can be quite challenging because enlarged lymph nodes 
tend to be the first and only symptom. The prognosis 
and survival of patients with NEC is poor [1, 2], and so 
it has been recommended that physical examination 
as well as biochemical, functional, and imaging tests 
be performed every 3 months [3]. A thorough physical 
examination of the skin should also be performed to 
look for possible metastases. Because our patient’s clini-
cal course proved extremely aggressive, we would like 
to strongly emphasize that diagnostic imaging should 
be repeated immediately prior to qualifying the patient 
for surgery. Correct determination of disease stage sup-
ports treatment planning and helps avoid unintended 
qualification for surgery.
A 49-year-old female patient started the diagnosis 
due to enlargement of the right inguinal lymph 
nodes. A lymph node packet (52 × 28 × 36 mm) re-
vealed on ultrasound was excised. Histopathology of 
the surgical specimen showed metastasis of small cell 
NEC G3. Immunophenotyping revealed the following: 
ChrA (+), SYN (+), AE1/3 (+) (dot), TTF-1 (–), and 
a Ki-67 index of 65%. Despite examination by two in-
dependent centres, the location of the primary tumour 
(TxN1Mx) was not identified. 
In order to search for the primary lesion, computed 
tomography (CT) of the abdominopelvic cavity was per-
formed, visualizing a packet of lymph nodes (48 × 32 mm) 
on the right side of the lesser pelvis, at the level of the 
external iliac vessels. In somatostatin receptors scintig-
raphy with 99mTc-Tektrotyd revealed overexpression of 
somatostatin receptors in the lymph nodes seen at CT. 
The primary focus remained undetected on gynaecologi-
cal and laryngological consultations, thyroid and breast 
ultrasound, colonoscopy, and chest CT. CT scans ob-
tained 3 months later showed an enlarged nodal packet. 
18F-FDG PET/CT demonstrated a metabolically active 
process only in the external right iliac lymph nodes 
(SUVmax. 6.5) (Fig. 1A, B). Neuroendocrine tumour 
markers were normal. 68Ga-DOTATATE PET-CT 2 months 
later showed increased expression of somatostatin 
receptors (SUVmax 10.5 and 17.4) but only in the exter-
nal right iliac lymph node packets of 59 × 37 mm and 
66 × 41 mm in size. The patient was qualified for nodal 
packet excision and for the search for the primary lesion. 
Because the packets proved unresectable during surgery, 
the patient received palliative chemotherapy (cisplatin 
and etoposide), which was continued for 5 months. Ab-
dominopelvic CT scan performed after the 6th cycle of 
chemotherapy showed almost complete regression. 
Six months later, a 18F-FDG PET-CT scan showed 
metabolic progression of the nodal infiltration in the 
pelvic area (67 × 47 × 116 mm). Due to the progression 
of the disease, locoregional advancement, and post-che-
motherapy polyneuropathy, the patient was qualified 
for palliative hypofractionated radiotherapy (a total 
dose of 30 Gy in 10 fractions). Abdominal CT performed 
3 months later revealed a solid 22-mm tumour of the 
pancreatic body, classified as the primary lesion (Fig. 2), 
and a stable disease in the pelvic lymph nodes according 
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ment, which she did not receive due to her rapidly 
deteriorating general condition. Unfortunately, the 
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to Response Evaluation Criteria in Solid Tumours. The 
pancreatic tumour was considered resectable and the 
patient was qualified for elective surgery.
Two weeks after the above CT examination, the 
patient reported a rapidly enlarging tumour of the 
right forearm, now measuring 15 × 30 × 20 mm. 
Another CT was performed prior to surgery for pan-
creatic tumour, revealing significant progression of the 
tumour to 31 × 26 mm, and metastatic lymph nodes 
(51 × 41 × 87 mm). Due to infiltration of the celiac trunk 
and hepatic artery (Fig. 3), the tumour was considered 
unresectable, and surgery was cancelled. Because 
the nature of the right forearm tumour had not been 
clarified, the lesion was excised. The histopathological 
examination revealed G3 NEC metastasis with a Ki-67 
of 90% and mitotic index of 10/10 HPF (Fig. 4A, B). The 
patient was qualified for palliative oncological treat-
Figure 3. Abdominopelvic CT scan. Unresectable tumour of the 
pancreatic body with metastatic lymph nodes (arrow)
Figure 1. 18F-FDG PET-CT. a. Normal pancreas (arrow). 
B. Metastatic lymph nodes on the right side of the lesser pelvis 
at the level of the external iliac vessels (arrow)
A
B
Figure 2. CT scan of the abdominopelvic cavity. Resectable tumour 
of the pancreatic body (arrow)
A
B
Figure 4. Histology with immunohistochemistry of NEC 
metastasis. a. Chromogranin A (10×). B. Ki-67 index of approx. 
90% (10×)
